Conflict of Interest Disclosure in Off-Label Oncology Clinical Trials

PURPOSE: We sought to determine the prevalence, reliability, and predictors of conflict of interest (COI) and funding disclosure statements for studies of anticancer targeted therapies conducted in the off-label prescribing setting. METHODS: As a part of a federally funded systematic review, manuscr...

Full description

Saved in:
Bibliographic Details
Main Authors: Irwin, Blair, Hirsch, Bradford R., Samsa, Gregory P., Abernethy, Amy P.
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2012
Subjects:
Health Policy
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3439230/
https://ncbi.nlm.nih.gov/pubmed/23277767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2011.000523
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items